🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT06648018
Enrolling by invitation Not applicable

Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women

NCT06648018 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2024-10-15
Last updated
2024-10-18

Condition(s) studied

Well Being

Investigational drug(s) / intervention(s)

Nutritional informationIron-succinate

Nutritional information: Written nutritional information about food with high content of iron.

Iron-succinate: 100 mg of Iron-succinate per day.

Study summary

The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years for 8 weeks. The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and body weight results through the same system. Participants will be randomized 1:1 to either follow written dietary recommendations to increase their dietary iron intake, or to use a daily oral supplement of 100 mg of iron succinate. Study parameters are blood tests (fasting blood samples will be collected by a licensed laboratory: serum iron, serum transferrin, serum transferrin saturation, serum ferritin, and serum soluble transferrin receptor, blood status (hemoglobin, MCV, MCH, MCHC, thrombocytes, leukocytes), and plasma high-sensitivity C-reactive protein (hsCRP) and Body height and weight as well as questionnaires.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: Inclusion criteria will be menstruating women aged 20 to 40 years who are healthy and regularly exercise. \- Exclusion Criteria: Significant disease affecting inflammation and/or hemoglobin levels. Inability to cooperate or to fill out questionnaires. \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine and Health Sciences Linköping University Linköping Sweden

More University Hospital, Linkoeping trials in Sweden

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06648018 on ClinicalTrials.gov ↗ ← All trials in Sweden